Literature DB >> 16440439

Percutaneous local therapies for hepatocellular carcinoma impair gastric function.

Fumihiko Kinekawa, Kazuya Matsuda, Tsutomu Masaki, Kazutaka Kurokohchi, Hirohito Yoneyama, Hideyuki Inoue, Hirohide Kurata, Yoshihito Uchida, Seishiro Watanabe, Shigeki Kuriyama.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16440439      PMCID： PMC4077495          DOI： 10.3748/wjg.v12.i1.157

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN： 1007-9327            Impact factor:   5.742


× No keyword cloud information.
  11 in total

1.  Pitfalls in the analysis of electrogastrographic recordings.

Authors:  M A Verhagen; L J Van Schelven; M Samsom; A J Smout
Journal:  Gastroenterology       Date:  1999-08       Impact factor: 22.682

2.  Enlargement of thermal ablation zone by the combination of ethanol injection and radiofrequency ablation in excised bovine liver.

Authors:  Seishiro Watanabe; Kazutaka Kurokohchi; Tsutomu Masaki; Yoshiaki Miyauchi; Toshiharu Funaki; Hideyuki Inoue; Takashi Himoto; Yuko Kita; Naohito Uchida; Tetsuo Touge; Toshiaki Tatsukawa; Shigeki Kuriyama
Journal:  Int J Oncol       Date:  2004-02       Impact factor: 5.650

3.  Successful laparoscopic radiofrequency ablation of hepatocellular carcinoma adhered to the mesentery after transcatheter arterial embolization.

Authors:  Kazutaka Kurokohchi; Tsutomu Masaki; Takashi Himoto; Akihiro Deguchi; Seiji Nakai; Hirohito Yoneyama; Shuhei Yoshida; Yasuhiko Kimura; Hideyuki Inoue; Fumihiko Kinekawa; Akira Yoshitake; Kunihiko Izuishi; Seishiro Watanabe; Shigeki Kuriyama
Journal:  Oncol Rep       Date:  2005-01       Impact factor: 3.906

4.  Comparison between combination therapy of percutaneous ethanol injection and radiofrequency ablation and radiofrequency ablation alone for patients with hepatocellular carcinoma.

Authors:  Kazutaka Kurokohchi; Seishiro Watanabe; Tsutomu Masaki; Naoki Hosomi; Yoshiaki Miyauchi; Takashi Himoto; Yasuhiko Kimura; Seiji Nakai; Akihiro Deguchi; Hirohito Yoneyama; Shuhei Yoshida; Shigeki Kuriyama
Journal:  World J Gastroenterol       Date:  2005-03-14       Impact factor: 5.742

5.  GSRS--a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease.

Authors:  J Svedlund; I Sjödin; G Dotevall
Journal:  Dig Dis Sci       Date:  1988-02       Impact factor: 3.199

6.  Delayed gastrointestinal transit in patients with hepatocellular carcinoma.

Authors:  Chih-Yen Chen; Ching-Liang Lu; Full-Young Chang; Kang Lih-Jiun; Jiing-Chyuan Luo; Rei-Hwa Lu; Shou-Dong Lee
Journal:  J Gastroenterol Hepatol       Date:  2002-12       Impact factor: 4.029

7.  Mediation of transcatheter arterial chemoembolization induced gastric slow-wave dysrhythmia by endogenous prostaglandin.

Authors:  Chi-Sen Chang; Sheng-Sun Yang; Hong-Zen Yeh; Chung-Wang Ko; Han-Chung Lien; Gran-Hum Chen
Journal:  J Gastroenterol Hepatol       Date:  2002-01       Impact factor: 4.029

8.  Combined use of percutaneous ethanol injection and radiofrequency ablation for the effective treatment of hepatocelluar carcinoma.

Authors:  K Kurokohchi; S Watanabe; T Masaki; N Hosomi; T Funaki; K Arima; S Yoshida; Y Miyauchi; S Kuriyama
Journal:  Int J Oncol       Date:  2002-10       Impact factor: 5.650

9.  Percutaneous ethanol and lipiodol injection therapy for hepatocellular carcinoma.

Authors:  Kazutaka Kurokohchi; Tsutomu Masaki; Yoshiaki Miyauchi; Toshiharu Funaki; Hirohito Yoneyama; Hisaaki Miyoshi; Shuhei Yoshida; Takashi Himoto; Asahiro Morishita; Naohito Uchida; Seishiro Watanabe; Shigeki Kuriyama
Journal:  Int J Oncol       Date:  2004-02       Impact factor: 5.650

10.  Efficacy of combination therapies of percutaneous or laparoscopic ethanol-lipiodol injection and radiofrequency ablation.

Authors:  Kazutaka Kurokohchi; Tsutomu Masaki; Yoshiaki Miyauchi; Naoki Hosomi; Hirohito Yoneyama; Shuhei Yoshida; Takashi Himoto; Akihiro Deguchi; Seiji Nakai; Hideyuki Inoue; Seishiro Watanabe; Shigeki Kuriyama
Journal:  Int J Oncol       Date:  2004-12       Impact factor: 5.650
View more
  2 in total

1.  Percutaneous ethanol ablation of hepatocellular carcinoma: periprocedural onset alcohol toxicity and pancreatitis following conventional percutaneous ethanol ablation treatment.

Authors:  Kirsteen Rennie Burton; Helena O'Dwyer; Charles Scudamore
Journal:  Can J Gastroenterol       Date:  2009-08       Impact factor: 3.522

2.  Influence of percutaneous local therapy for hepatocellular carcinoma on gastric function.

Authors:  Mitsuyoshi Kobayashi; Fumihiko Kinekawa; Kazuya Matsuda; Shintaro Fujihara; Noriko Nishiyama; Takako Nomura; Joji Tani; Hisaaki Miyoshi; Hideki Kobara; Akihiro Deguchi; Hirohito Yoneyama; Hirohito Mori; Tsutomu Masaki
Journal:  World J Gastroenterol       Date:  2013-03-14       Impact factor: 5.742
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.